INS and type 1 diabetes mellitus: In the absence of endogenous insulin secretion, in type 1 diabetes (T1D), circulating IGFBP-1 concentrations are disproportionately increased in relation to whole-body insulin sensitivity, measured by a euglycemic hyperinsulinemic clamp [49].